Outcomes and Prognostic Factors in Hepatopancreatoduodenectomy
NCT ID: NCT06631352
Last Updated: 2024-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2000-01-01
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. Hepatopancreatoduodenectomy(HPD) has been considered a surgical option for patients with extensive bile duct or gallbladder cancer to achieve an R0 resection.
3. The associated high morbidity and mortality rates have prevented HPD from becoming a standard surgical procedure worldwide.
4. Over the past few decades, the understanding of the bile duct anatomy has significantly improved, and many methods have been developed to assess liver function and future remnant liver volume.
5. We aimed to evaluate the short- and long-term outcomes of HPD and to assess risk factors associated with survival, early recurrence, and major complications to better evaluate the potential of the procedure as a standard treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery
NCT01657383
Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers
NCT01134276
Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy
NCT02784353
Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy
NCT01913275
Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study
NCT06720883
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GB cancer
Patients who were diagnosed with gallbladder cancer and underwent the hepatopancreatoduodenectomy.
Hepatopancreatoduodenectomy
Pancreatoduodenectomy with liver resection
CCA
Patients who were diagnosed with cholangiocarcinoma and underwent the hepatopancreatoduodenectomy.
Hepatopancreatoduodenectomy
Pancreatoduodenectomy with liver resection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hepatopancreatoduodenectomy
Pancreatoduodenectomy with liver resection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jin-Young Jang
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2407-049-1551
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.